1. Home
  2. QURE vs AGYS Comparison

QURE vs AGYS Comparison

Compare QURE & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$24.11

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Agilysys Inc.

AGYS

Agilysys Inc.

N/A

Current Price

$121.66

Market Cap

3.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QURE
AGYS
Founded
1998
1963
Country
Netherlands
United States
Employees
248
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
QURE
AGYS
Price
$24.11
$121.66
Analyst Decision
Strong Buy
Buy
Analyst Count
13
8
Target Price
$59.78
★ $142.33
AVG Volume (30 Days)
★ 1.7M
288.3K
Earning Date
11-04-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
29.67
★ 67.07
EPS
N/A
★ 0.78
Revenue
$13,107,000.00
★ $319,312,000.00
Revenue This Year
$44.21
$17.70
Revenue Next Year
$398.45
$17.26
P/E Ratio
★ N/A
$155.85
Revenue Growth
N/A
★ 15.85
52 Week Low
$8.73
$61.50
52 Week High
$51.72
$129.32

Technical Indicators

Market Signals
Indicator
QURE
AGYS
Relative Strength Index (RSI) 46.32 60.79
Support Level $20.63 $103.53
Resistance Level $26.01 $123.80
Average True Range (ATR) 1.93 4.81
MACD 0.68 -0.07
Stochastic Oscillator 57.62 73.98

Price Performance

Historical Comparison
QURE
AGYS

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

Share on Social Networks: